Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qomel CoSAU:9600 +2.13%23 EBIT per Share is ﷼2.92 as of Dec. 2025. GuruFocus rates SAU:9600 with a GF Score™ of 23/100. The stock has 3 warning signs investors should review. Among 525 Healthcare Providers & Services companies, Qomel Co ranks worse than 190476% on this metric.
Qomel Co's EBIT per Share for the
six
months ended in Dec. 2025 was ﷼0.79.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼2.92.
During the past 12 months, the average EBIT per Share Growth Rate of Qomel Co was -25.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Qomel Co's EBIT per Share or its related term are showing as below:
SAU:9600's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Qomel Co's EBIT for the
six
months ended in Dec. 2025 was ﷼5.6 Mil.
Qomel Co (SAU:9600) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Qomel Co EBIT per Share Related Terms
Qomel Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Qomel Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ﷼2.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qomel Co (SAU:9600) has a EBIT per Share of ﷼2.92 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Qomel Co and its competitors. According to the industry distribution chart, Qomel Co ranks #999999 out of 525 companies in the Healthcare Providers & Services industry.
Is Qomel Co's EBIT per Share too high?
Qomel Co's current EBIT per Share is ﷼2.92. Based on the distribution chart, Qomel Co ranks #999999 out of 525 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Qomel Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Qomel Co's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Qomel Co ranks #999999 out of 525 companies for EBIT per Share. This places Qomel Co in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Qomel Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qomel Co's current EBIT per Share is ﷼2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qomel Co stock overvalued right now?
Qomel Co (SAU:9600) has a current EBIT per Share of ﷼2.92. The current EBIT per Share is ﷼2.92. Qomel Co's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Qomel Co (SAU:9600), the current EBIT per Share is ﷼2.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qomel Co is a Saudi Arabian-based healthcare company that provides high-quality medicines and innovative medical services whose core business focuses on institutional and government supply through a professional field force and an in-depth knowledge of the local business environment They offer services such as pharmaceutical and medical supplies.
23GF Score
Get the complete analysis for SAU:9600
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9600 has been successfully added to your 
